Postoperative Pain Relieve for Patients Undergoing Surgical Treatment of Femoral Fracture

NCT ID: NCT05920642

Last Updated: 2025-11-25

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

PHASE4

Total Enrollment

82 participants

Study Classification

INTERVENTIONAL

Study Start Date

2023-09-04

Study Completion Date

2025-07-29

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The aim of the study is to investigate postoperative pain relief for patients undergoing surgical treatment of proximal femoral fracture using intrathecal administration of morphine.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

In this study, the investigators will compare the efficiency of intrathecal morphine administration with the standard of care (parenteral application of analgesics) for pain relief in patients after proximal femoral fracture surgery. The secondary outcome measure will be to determine the frequency of adverse effects of intrathecally administered morphine. The study will be monocentric, randomized, and single-blinded. A total of 50 patients are expected to be enrolled.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Proximal Femur Fracture

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

The study subjects will be randomized into two parallel groups.
Primary Study Purpose

TREATMENT

Blinding Strategy

SINGLE

Participants
The participant will not know which arm of the study he/she has been enrolled into.

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Intrathecal morphine administration

Study subjects randomized into this arm will be administered morphine intrathecally in the dose of dose 100 ug.

Group Type EXPERIMENTAL

Intrathecal morphine administration

Intervention Type DRUG

Administration of morphine into the spinal canal.

Parenteral administration of analgesics

Study subjects randomized into this arm will receive standard postoperative pain management (parenteral administration of analgesics).

Group Type ACTIVE_COMPARATOR

Parenteral administration of analgesics

Intervention Type DRUG

Standard postoperative pain management of analgesics using parenteral route of administration.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Intrathecal morphine administration

Administration of morphine into the spinal canal.

Intervention Type DRUG

Parenteral administration of analgesics

Standard postoperative pain management of analgesics using parenteral route of administration.

Intervention Type DRUG

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* signed informed consent
* 60 to 90 years of age
* surgical treatment of proximal femur fracture
* The American Society of Anesthesiologists (ASA) classification I to III
* spinal anesthesia used for the operation

Exclusion Criteria

* general anesthesia used for the operation
* allergy to opioids
* high risk of respiratory depression
Minimum Eligible Age

60 Years

Maximum Eligible Age

90 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

University Hospital Ostrava

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Denis Buršík, MD

Role: PRINCIPAL_INVESTIGATOR

University Hospital Ostrava

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

University Hospital Ostrava

Ostrava, Moravian-Silesian Region, Czechia

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Czechia

References

Explore related publications, articles, or registry entries linked to this study.

Rathmell JP, Pino CA, Taylor R, Patrin T, Viani BA. Intrathecal morphine for postoperative analgesia: a randomized, controlled, dose-ranging study after hip and knee arthroplasty. Anesth Analg. 2003 Nov;97(5):1452-1457. doi: 10.1213/01.ANE.0000083374.44039.9E.

Reference Type BACKGROUND
PMID: 14570664 (View on PubMed)

Yamashita K, Fukusaki M, Ando Y, Tanabe T, Terao Y, Sumikawa K. Postoperative analgesia with minidose intrathecal morphine for bipolar hip prosthesis in extremely elderly patients. J Anesth. 2009;23(4):504-7. doi: 10.1007/s00540-009-0817-5. Epub 2009 Nov 18.

Reference Type BACKGROUND
PMID: 19921358 (View on PubMed)

Kwan AS, Lee BB, Brake T. Intrathecal morphine for post-operative analgesia in patients with fractured hips. Hong Kong Med J. 1997 Sep;3(3):250-255.

Reference Type BACKGROUND
PMID: 11847368 (View on PubMed)

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

2021-002765-17

Identifier Type: EUDRACT_NUMBER

Identifier Source: secondary_id

FNO-KARIM2021-1

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

NSAIDS vs Opioids in Tibial Fractures
NCT05332314 UNKNOWN PHASE4